These indicated that PD-L1 or PD-1 expression on non-tumor cells may be useful for guiding treatment of HNSCC and the prognostic role of PD-L1 expression combined with immune cells infiltrating should be further investigated. The gene discussed is CD274; the disease is neoplasm.